Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Yvonne Greenstreet
Pharma
Alnylam drafts $250M upgrade to its Mass. drug factory
With demand for its RNA interference meds booming, Alnylam has commenced work to soup up its flagship manufacturing facility in Massachusetts.
Fraiser Kansteiner
Dec 17, 2025 10:12am
Alnylam's market cap jumps past $50B
Aug 1, 2025 7:39am
Alnylam founder Maraganore, successor Greenstreet get pay bumps
Apr 7, 2022 10:52am
Alnylam founding CEO Maraganore steps down
Oct 28, 2021 11:05am
